Jose L. Navia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jose L. Navia has a total of 158 co-authors. Here are the top co-authors by number of shared publications:
Haytham Elgharably
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
10 shared publicationsEugene H. Blackstone
Department of Thoracic and Cardiovascular Surgery, Department of Quantitative Health Sciences, Cleveland Clinic, 9500 Euclid Ave, Desk J4-1, Cleveland, OH 44143
8 shared publicationsFernando A. Atik
8 shared publicationsLars G. Svensson
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
6 shared publicationsA. Marc Gillinov
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
5 shared publicationsBruce W. Lytle
Department of Cardiac and Thoracic Surgery, Baylor Scott & White, The Heart Hospital, Plano, Texas
5 shared publications
Latest Publications
- 1 January 2024
- Published by Springer Nature
- p. 439-444
The Hemi-Commando Procedure for Endocarditis of the Aortic Root and Aortomitral Fibrosa
- 1 January 2024
- Published by Springer Nature
- p. 439-444
The Hemi-Commando Procedure for Endocarditis of the Aortic Root and Aortomitral Fibrosa
- Open Access
- 10 October 2023
- Published by Elsevier in JTCVS Techniques
- Vol. 22, 88-89
The hemi-commando procedure
- 10 October 2023
- Published by Elsevier in JTCVS Techniques
- Vol. 22, 88-89
Open AccessThe hemi-commando procedure
- Open Access
- 11 August 2023
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 1 (4) , 650-652
Aortic Valve Papillary Fibroelastoma: Robotic Excision and Noncoronary Aortic Valve Repair
- 11 August 2023
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 1 (4) , 650-652
Open AccessAortic Valve Papillary Fibroelastoma: Robotic Excision and Noncoronary Aortic Valve Repair
- Open Access
- 1 April 2023
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 1 (3) , 404-406
Alternative Surgical Repair: Anomalous Left Coronary From the Pulmonary Artery Syndrome in Adulthood
- 1 April 2023
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 1 (3) , 404-406
Open AccessAlternative Surgical Repair: Anomalous Left Coronary From the Pulmonary Artery Syndrome in Adulthood
- Open Access
- 31 March 2023
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 1 (3) , 411-414
Multivalvular Endocarditis: A Different Approach
- 31 March 2023
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 1 (3) , 411-414
Open AccessMultivalvular Endocarditis: A Different Approach
- Open Access
- 16 March 2022
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 6 (1) , 1-14
Prognostic value of patient-reported outcome measures in adult heart-transplant patients: a systematic review
Background: The aim of this systematic review was to describe the prognostic value of patient-reported outcome measures (PROMs) in adult heart-transplant (HT) patients. Methods: A systematic search was performed on Ovid Medline, CINAHL Plus, Web of Science, and PubMed. The study protocol was registered on the PROSPERO database (CRD42021225398), and the last search was performed on January 7, 2021. We included studies of adult HT patients where generic and disease-specific PROMs were used as prognostic indicators for survival, readmissions, HT complications, and the onset of new comorbidities. We excluded studies that used clinician-reported and patient-experience outcomes. The Quality in Prognosis Studies tool (QUIPS) was used to measure the risk of bias of the included studies. Results: We included five observational studies between 1987 and 2015, whose populations’ mean age ranged from 43 to 56 years and presented a higher proportion of males than females. The Kansas City Cardiomyopathy Questionnaire demonstrated a negative correlation with readmissions (coefficient = − 1.177, p = 0.031), and the EQ-5D showed a negative correlation with the onset of neuromuscular disease after HT (coefficient = − 0.158, p < 0.001). The Millon Behavioral Health Inventory and the Nottingham Health Profile demonstrated a statistically significant association as survival predictors (p = 0.002 and p < 0.05, respectively). A moderate overall risk of bias was reported in three studies, one study resulted in a low risk of bias, and a proportion of more than 75% of males in each of the studies. High heterogeneity between the studies impeded establishing a link between PROMs and prognostic value. Conclusion: There is low evidence supporting PROMs usage as prognostic tools in adult HT patients. Comparing outcomes of PROMS to routine prognostic in wider and systematic settings is warranted. Systematic use of PROMs in clinical settings is warranted.
- 16 March 2022
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 6 (1) , 1-14
Open AccessPrognostic value of patient-reported outcome measures in adult heart-transplant patients: a systematic review
Background: The aim of this systematic review was to describe the prognostic value of patient-reported outcome measures (PROMs) in adult heart-transplant (HT) patients. Methods: A systematic search was performed on Ovid Medline, CINAHL Plus, Web of Science, and PubMed. The study protocol was registered on the PROSPERO database (CRD42021225398), and the last search was performed on January 7, 2021. We included studies of adult HT patients where generic and disease-specific PROMs were used as prognostic indicators for survival, readmissions, HT complications, and the onset of new comorbidities. We excluded studies that used clinician-reported and patient-experience outcomes. The Quality in Prognosis Studies tool (QUIPS) was used to measure the risk of bias of the included studies. Results: We included five observational studies between 1987 and 2015, whose populations’ mean age ranged from 43 to 56 years and presented a higher proportion of males than females. The Kansas City Cardiomyopathy Questionnaire demonstrated a negative correlation with readmissions (coefficient = − 1.177, p = 0.031), and the EQ-5D showed a negative correlation with the onset of neuromuscular disease after HT (coefficient = − 0.158, p < 0.001). The Millon Behavioral Health Inventory and the Nottingham Health Profile demonstrated a statistically significant association as survival predictors (p = 0.002 and p < 0.05, respectively). A moderate overall risk of bias was reported in three studies, one study resulted in a low risk of bias, and a proportion of more than 75% of males in each of the studies. High heterogeneity between the studies impeded establishing a link between PROMs and prognostic value. Conclusion: There is low evidence supporting PROMs usage as prognostic tools in adult HT patients. Comparing outcomes of PROMS to routine prognostic in wider and systematic settings is warranted. Systematic use of PROMs in clinical settings is warranted.
- 1 November 2019
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 62 (6) , 493-495
Transcatheter innovations in tricuspid regurgitation: Navigate
- 1 November 2019
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 62 (6) , 493-495
Transcatheter innovations in tricuspid regurgitation: Navigate
- 1 November 2019
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 108 (5) , 1314-1323
Long-term Outcomes of Surgery for Invasive Valvular Endocarditis Involving the Aortomitral Fibrosa
- 1 November 2019
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 108 (5) , 1314-1323
Long-term Outcomes of Surgery for Invasive Valvular Endocarditis Involving the Aortomitral Fibrosa
- 1 March 2018
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 105 (3) , 986
Reply
- Open Access
- 1 February 2018
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 3 (1) , 67-79
Transcatheter Tricuspid Valve Implantation of NaviGate Bioprosthesis in a Preclinical Model
- 1 February 2018
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 3 (1) , 67-79
Open AccessTranscatheter Tricuspid Valve Implantation of NaviGate Bioprosthesis in a Preclinical Model